Dáil Éireann Debate, Tuesday - 21 March 2017
992. Deputy Richard Boyd Barrett asked the Minister for Health if the HPRA has met representatives of the pharmaceutical industry or other interested parties to discuss the Cannabis for Medicinal Use Regulation Bill 2016; if there are minutes of these meetings; if so, the outcomes of such meetings; and if he will make a statement on the matter. [14077/17]
View answerThe Health Products Regulatory Authority (HPRA) has confirmed that it has not held meetings with pharmaceutical industry or other interested parties to discuss the Cannabis for Medicinal Use Regulation Bill 2016.
In the course of preparing the HPRA Cannabis Scientific Review report requested by me, the HPRA held meetings or teleconferences with some companies that are manufacturing and/or supplying cannabis products, as well as with regulators, clinical and scientific researchers, and patient representatives.
